About Fagron
Fagron is a company based in Saint Paul (United States) founded in 1990. Fagron has completed 9 acquisitions, including Amber Compounding Pharmacy, CareFirst Specialty Pharmacy and Cedrosa. Fagron offers products and services including Fagron Formulary, DiluCap, Pentravan®, SyrSpend®, and FagronLab™. Fagron operates in a competitive market with competitors including RareStone Group, Revelation Pharma, Pharmedium, Syntis and Ceban, among others.
- Headquarter Saint Paul, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fagron Nordic A/S
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Amber Compounding Pharmacy
& 8 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fagron
Fagron offers a comprehensive portfolio of products and services, including Fagron Formulary, DiluCap, Pentravan®, SyrSpend®, and FagronLab™.
Offers customized formulas for pharmaceutical prescriptions and indications.
Matches excipients with APIs for effective formulations.
Provides base for transdermal drug delivery applications.
Enables oral suspension of pharmaceutical compounds.
Supplies global line of tools for pharmaceutical compounding.
Delivers courses and training for pharmaceutical professionals.
People of Fagron
Unlock access to complete
Unlock access to complete
Funding Insights of Fagron
Detailed funding history for Fagron
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fagron
Fagron has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Amber Compounding Pharmacy, CareFirst Specialty Pharmacy and Cedrosa.
Investment portfolio details for Fagron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Compounding services for prescription drugs are provided to healthcare providers.
|
Locked | Locked | 2014 | Locked | |
|
Customized medicines are provided by Amber Compounding Pharmacy.
|
Locked | Locked | 2008 | Locked | |
|
Consumer electronics and home appliances are manufactured by HiperScan.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Fagron
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Fagron
Detailed financials for Fagron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fagron Comparisons
Peer comparison for Fagron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fagron
Fagron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RareStone Group, Revelation Pharma, Pharmedium, Syntis and Ceban, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of network and treatments to individuals and their families affected by rare diseases drugs
|
|
| Locked | Locked | Locked |
A network of compounding pharmacies is operated nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided to healthcare facilities nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided by Syntis in healthcare.
|
|
| Locked | Locked | Locked |
Compounding pharmacy services are offered independently in Breda.
|
Detailed competitors of Fagron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fagron
Complete news archive for Fagron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fagron
Fagron was founded in 1990.
Fagron is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Rafael Padilla is the current CEO of Fagron.
The company was founded in 1990 and is headquartered in Saint Paul, United States. Operations are centered on drug compounding within the pharmaceutical sector, where customized medications are prepared for healthcare applications. Services include sterile and non-sterile compounding to meet specific patient and provider needs. Leadership is held by CEO Rafael Padilla, overseeing activities across the domain fagron.com.
Fagron's top competitors include Syntis, Medac and RareStone Group.
Fagron offers Fagron Formulary, DiluCap, Pentravan®, SyrSpend®, and 2 more products and services.
Fagron has made 9 acquisitions, including Amber Compounding Pharmacy, CareFirst Specialty Pharmacy, and Cedrosa.